Kirkland-Led Transcend Bought By Otsuka In $1.2B Deal
Clinical-stage biotechnology company Transcend Therapeutics Inc., led by Kirkland & Ellis LLP and Pillsbury Winthrop Shaw Pittman LLP, on Friday announced that it has agreed to be bought by Otsuka Pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article